Date |
Division Click to filter
|
Latest News |
22-Oct-2020 |
Corporate |
Eurofins reports very strong performance with organic growth exceeding 22% in Q3 2020 and sets new objectives for 2022
Q3 2020 revenues increased 21.0% year-on-year to EUR 1,413m vs. EUR 1,167m in Q3 2019. Over the firs...
|
6-Aug-2020 |
Corporate |
Eurofins reports solid growth of revenues, profits and cash flows in H1 2020 and continued positive organic growth in Q2 in spite of the COVID-19 pandemic
At the onset of the COVID-19 pandemic, Eurofins’ priorities were (i) to protect its staff, (ii) to e...
|
14-Jul-2020 |
Corporate |
Eurofins publishes robust method to analyse SARS-CoV-2 in wastewater samples, providing early warning of potential COVID-19 outbreak at a given site
A study undertaken by Eurofins scientists has resulted in a robust method to analyse SARS-CoV-2 in w...
|
1-Jul-2020 |
Corporate |
Eurofins publishes method for early detection of asymptomatic SARS-CoV-2 virus spreaders, that does not require human PCR clinical testing
Although employees showing COVID-19 symptoms are currently discouraged from going to work, significa...
|
29-May-2020 |
Corporate |
Eurofins Launches Eurofins SAFER@WORK™: a Comprehensive Suite of Risk-Based COVID-19 Safety Solutions for Businesses
Eurofins launched today globally Eurofins SAFER@WORK™, a suite of integrated risk-based solutions fo...
|
28-Apr-2020 |
Corporate |
Eurofins scientists develop multiple new solutions to support the world’s fight against the COVID-19 pandemic – ramping up production to enable over 20 million patients tests per month by end May 2020 Activity shows strong resilience in Q1 2020
From the onset of the COVID-19 crisis, Eurofins leadership’s priority has been to mobilise all avail...
|
17-Apr-2020 |
Clinical Diagnostics |
Eurofins Technologies launches multiple CE-IVD marked serologic products
Eurofins Technologies launches multiple CE-IVD marked serologic products for the detection of antibo...
|
27-Mar-2020 |
Clinical Diagnostics |
Testing solutions for SARS-CoV-2 on surfaces
Eurofins Technologies launches testing solutions for the detection of SARS-CoV-2 on environmental su...
|
19-Mar-2020 |
Corporate |
Eurofins Scientific Supports Healthcare Authorities in Europe, the U.S.A. and Brazil in their Fight against the COVID-19 Pandemic with Additional Testing Options and Fast Growing Capacity
Eurofins, a global leader in testing and laboratory services, announces that, in addition to the U.S...
|
12-Mar-2020 |
Corporate |
Eurofins Scientific Supports SARS-CoV-2 Analyses needs in the U.S.A. and in Europe with Multiple Testing Options
Eurofins, a global leader in testing and laboratory services, announces that two of its clinical dia...
|
|